Boston Family Office’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-10,410
| Closed | -$787K | – | 316 |
|
|
2026
Q1 | $787K | Hold |
10,410
| – | – | 0.05% | 187 |
|
|
2025
Q4 | $775K | Sell |
10,410
-8,587
| -45% | -$627K | 0.05% | 176 |
|
|
2025
Q3 | $1.28M | Hold |
18,997
| – | – | 0.08% | 145 |
|
|
2025
Q2 | $1.24M | Hold |
18,997
| – | – | 0.08% | 155 |
|
|
2025
Q1 | $1.17M | Hold |
18,997
| – | – | 0.08% | 147 |
|
|
2024
Q4 | $1.37M | Hold |
18,997
| – | – | 0.09% | 136 |
|
|
2024
Q3 | $1.55M | Sell |
18,997
-437
| -2% | -$35K | 0.1% | 128 |
|
|
2024
Q2 | $1.44M | Sell |
19,434
-2
| -0% | -$150 | 0.1% | 126 |
|
|
2024
Q1 | $1.51M | Sell |
19,436
-162
| -0.8% | -$12.1K | 0.11% | 127 |
|
|
2023
Q4 | $1.4M | Sell |
19,598
-249
| -1% | -$17.3K | 0.11% | 131 |
|
|
2023
Q3 | $1.38M | Sell |
19,847
-1
| -0% | -$76 | 0.11% | 125 |
|
|
2023
Q2 | $1.61M | Sell |
19,848
-857
| -4% | -$70K | 0.12% | 120 |
|
|
2023
Q1 | $1.67M | Sell |
20,705
-125
| -0.6% | -$10.1K | 0.13% | 118 |
|
|
2022
Q4 | $1.56M | Sell |
20,830
-300
| -1% | -$21.4K | 0.13% | 122 |
|
|
2022
Q3 | $1.36M | Sell |
21,130
-24
| -0.1% | -$1.66K | 0.12% | 124 |
|
|
2022
Q2 | $1.47M | Sell |
21,154
-443
| -2% | -$32.9K | 0.12% | 119 |
|
|
2022
Q1 | $1.66M | Sell |
21,597
-976
| -4% | -$70.2K | 0.12% | 123 |
|
|
2021
Q4 | $1.73M | Hold |
22,573
| – | – | 0.11% | 127 |
|
|
2021
Q3 | $1.67M | Hold |
22,573
| – | – | 0.12% | 126 |
|
|
2021
Q2 | $1.51M | Sell |
22,573
-100
| -0.4% | -$6.68K | 0.11% | 139 |
|
|
2021
Q1 | $1.69M | Sell |
22,673
-201
| -0.9% | -$15.3K | 0.13% | 128 |
|
|
2020
Q4 | $1.67M | Sell |
22,874
-271
| -1% | -$19.1K | 0.13% | 124 |
|
|
2020
Q3 | $1.54M | Sell |
23,145
-850
| -4% | -$53.8K | 0.14% | 117 |
|
|
2020
Q2 | $1.37M | Sell |
23,995
-1,125
| -4% | -$55.2K | 0.13% | 124 |
|
|
2020
Q1 | $882K | Sell |
25,120
-3,075
| -11% | -$146K | 0.1% | 139 |
|
|
2019
Q4 | $1.47M | Hold |
28,195
| – | – | 0.14% | 128 |
|
|
2019
Q3 | $1.42M | Sell |
28,195
-5,350
| -16% | -$263K | 0.15% | 125 |
|
|
2019
Q2 | $1.61M | Sell |
33,545
-2,425
| -7% | -$112K | 0.17% | 119 |
|
|
2019
Q1 | $1.74M | Sell |
35,970
-10,870
| -23% | -$490K | 0.19% | 113 |
|
|
2018
Q4 | $1.93M | Sell |
46,840
-4,710
| -9% | -$193K | 0.24% | 102 |
|
|
2018
Q3 | $2.11M | Sell |
51,550
-1,225
| -2% | -$49.5K | 0.22% | 107 |
|
|
2018
Q2 | $2.1M | Sell |
52,775
-7,350
| -12% | -$283K | 0.24% | 107 |
|
|
2018
Q1 | $2.25M | Buy |
60,125
+160
| +0.3% | +$6.46K | 0.26% | 104 |
|
|
2017
Q4 | $2.56M | Buy |
59,965
+8,820
| +17% | +$352K | 0.28% | 99 |
|
|
2017
Q3 | $1.88M | Buy |
51,145
+18,350
| +56% | +$741K | 0.21% | 119 |
|
|
2017
Q2 | $1.49M | Buy |
32,795
+24,070
| +276% | +$1.06M | 0.18% | 129 |
|
|
2017
Q1 | $371K | Buy |
+8,725
| New | +$356K | 0.05% | 205 |
|
Other funds holding HOLX
Boston Family Office's HOLX Position: Q2 2026 in Review
Boston Family Office sold out of Hologic (HOLX) in Q2 2026, closing a stake of 10,410 shares — an estimated $787K sold.
Boston Family Office first reported a position in HOLX in Q1 2017 and held it in 37 quarters. The position peaked at $2.56M in Q4 2017. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Boston Family Office reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Boston Family Office sold 10,410 Hologic shares in Q2 2026, an estimated $787K.
- Boston Family Office first reported a position in Hologic in Q1 2017 and held it in 37 quarters.
- Boston Family Office's Hologic position peaked at $2.56M in Q4 2017.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Boston Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.